Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
3.
JACC Case Rep ; 3(10): 1322-1326, 2021 Aug 18.
Artículo en Inglés | MEDLINE | ID: mdl-34471887

RESUMEN

A 65-year-old immunocompromised woman presented with progressive dyspnea and sacroiliac joint pain. Cardiac magnetic resonance showed abnormal right ventricular filling with septal bounce and abnormal pericardial enhancement, suggestive of constrictive pericarditis. Cultures from pericardium following pericardiectomy grew Coccidioides immitis. She was diagnosed with coccidioidomycosis and responded to pericardiectomy and amphotericin. (Level of Difficulty: Intermediate.).

4.
BMJ Case Rep ; 14(1)2021 Jan 26.
Artículo en Inglés | MEDLINE | ID: mdl-33500298

RESUMEN

A 47-year-old man was referred for ongoing workup of an enlarging lung mass. Extensive workup of the mass had been unrevealing for several months until cultures grew Nocardia beijingensis He was successfully treated with trimethoprim/sulfamethoxazole and then doxycycline with near-complete resolution of the mass on follow-up. This case presents a rare species of N. beijingensis It highlights the importance of considering nocardiosis in immunocompetent adults and the challenge in initiating targeted treatment due to delayed culture results.


Asunto(s)
Absceso/diagnóstico por imagen , Mediastinitis/diagnóstico por imagen , Nocardiosis/diagnóstico por imagen , Nocardia , Neumonía Bacteriana/diagnóstico por imagen , Absceso/complicaciones , Absceso/tratamiento farmacológico , Antibacterianos/uso terapéutico , Biopsia , Biopsia con Aguja Gruesa , Sedimentación Sanguínea , Broncoscopía , Proteína C-Reactiva , Técnicas de Cultivo , Fístula Esofágica/diagnóstico , Fístula Esofágica/etiología , Humanos , Inmunocompetencia , Masculino , Enfermedades del Mediastino/diagnóstico , Enfermedades del Mediastino/etiología , Mediastinitis/complicaciones , Mediastinitis/tratamiento farmacológico , Persona de Mediana Edad , Nocardiosis/complicaciones , Nocardiosis/tratamiento farmacológico , Nocardiosis/patología , Neumonía Bacteriana/complicaciones , Neumonía Bacteriana/tratamiento farmacológico , Neumonía Bacteriana/patología , Tomografía de Emisión de Positrones , Cirugía Torácica Asistida por Video , Tomografía Computarizada por Rayos X
7.
Int J Infect Dis ; 62: 86-93, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28739424

RESUMEN

OBJECTIVES: The aim of this review is to provide updated information on the clinical spectrum, treatment options, and infection prevention strategies for respiratory viral infections (RVIs) in both solid organ (SOT) and hematopoietic stem cell transplant (HSCT) patients. METHODS: The MEDLINE and PubMed databases were searched for literature regarding the aforementioned aspects of RVIs, with focus on respiratory syncytial virus, adenovirus, influenza virus, parainfluenza virus, human metapneumovirus, and rhinovirus. RESULTS: Compared to immunocompetent hosts, SOT and HSCT patients are much more likely to experience a prolonged duration of illness, prolonged shedding, and progression of upper respiratory tract disease to pneumonia when infected with respiratory viruses. Adenovirus and respiratory syncytial virus tend to have the highest mortality and risk for disseminated disease, but all the RVIs are associated with higher morbidity and mortality in these patients than in the general population. These viruses are spread via direct contact and aerosolized droplets, and nosocomial spread has been reported. CONCLUSIONS: RVIs are associated with high morbidity and mortality among SOT and HSCT recipients. Management options are currently limited or lack strong clinical evidence. As community and nosocomial spread has been reported for all reviewed RVIs, strict adherence to infection control measures is key to preventing outbreaks.


Asunto(s)
Infecciones del Sistema Respiratorio/prevención & control , Infecciones del Sistema Respiratorio/virología , Receptores de Trasplantes , Brotes de Enfermedades , Trasplante de Células Madre Hematopoyéticas/efectos adversos , Humanos , Control de Infecciones , Metapneumovirus , Neumonía/epidemiología , Neumonía/virología , Virus Sincitial Respiratorio Humano , Infecciones del Sistema Respiratorio/epidemiología , Síndrome , Trasplantes/virología
8.
Int J Infect Dis ; 57: 138-143, 2017 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-28216179

RESUMEN

Hospital-acquired infections (HAIs) are a major concern to healthcare systems around the world. They are associated with significant morbidity and mortality, in addition to increased hospitalization costs. Recent outbreaks, including those caused by the Middle East respiratory syndrome coronavirus and Ebola virus, have highlighted the importance of infection control. Moreover, HAIs, especially those caused by multidrug-resistant Gram-negative rods, have become a top global priority. Although adequate approaches and guidelines have been in existence for many years and have often proven effective in some countries, the implementation of such approaches in low- and middle-income countries (LMICs) is often restricted due to limited resources and underdeveloped infrastructure. While evidence-based infection prevention and control (IPC) principles and practices are universal, studies are needed to evaluate simplified approaches that can be better adapted to LMIC needs, in order to guide IPC in practice. A group of experts from around the world attended a workshop held at the 17th International Congress on Infectious Diseases in Hyderabad, India in March 2016, to discuss the existing IPC practices in LMICs, and how best these can be improved within the local context.


Asunto(s)
Control de Infecciones , Infección Hospitalaria/epidemiología , Atención a la Salud , Países en Desarrollo , Brotes de Enfermedades , Recursos en Salud , Humanos , India , Pobreza
10.
Curr Infect Dis Rep ; 18(8): 25, 2016 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-27392413

RESUMEN

Healthcare-associated infections (HAIs) are an important cause of morbidity and mortality in the USA. They are associated with a substantial increase in health care costs each year. Fortunately, many HAIs are preventable, and their eradication is a national priority. Chlorhexidine (CHG) bathing has been used as an infection prevention measure, either alone or bundled with other interventions, with mostly beneficial results. The recent surge in its use as an agent of choice for skin antisepsis has lead to concerns over emerging resistance among microorganisms. Moreover, compliance with CHG-bathing protocols is not routinely monitored. Policies developed to determine the best infection prevention practice must consider that a "one-size-fits-all" strategy may lead to the selection of CHG-tolerant microorganisms, thereby emphasizing the need for more robust guidelines and additional studies on the role of chlorhexidine bathing for the prevention of HAIs.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...